MyOme hosted a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines moderated by Akash Kumar MD, PhD, featuring cardiology experts Akl Fahed, MD, MPH, and Michael Levin, MD.
Public source
Publisher name
Public post
Join cardiology experts Akl Fahed, MD, MPH, and Michael Levin, MD, for a roundtable discussion on the updated 2026 ACC/AHA Dyslipidemia Guidelines and what they mean for…
Company
MyOme
Empowering individuals to take control of their health through actionable genomic insights.
- Industry
- Biotechnology Research
- Location
- Palo Alto, US
- Company size
- 51–200 employees
About MyOme
Using whole genome sequencing and state-of-the-art bioinformatics, MyOme analyzes a single patient sample to produce comprehensive and clinically actionable reports that allow patients and their providers to make personalized lifestyle, prevention, and treatment choices.
See moreLatest activity
Latest activity from MyOme
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Genomadix
Genomadix hosted a live, complimentary webinar on September 10th, 2026, featuring a panel of experts on DAPT in PCI, gene-guided therapy, and rapid genetic testing.
Presence & Recognition
Cytokinetics
Cytokinetics presented new data at the ESC Congress 2026 in Munich alongside four simultaneous publications in cardiac journals.
Presence & Recognition
PacBio
PacBio hosted a webinar featuring two leading researchers discussing how long-read multiomics is advancing rare disease diagnostics, uncovering neurodegenerative mechanisms, and leveraging AI for therapeutic discovery.
Presence & Recognition
Touchlight
Touchlight featured two leading experts in The Great DNA Debate: Plasmid vs. Cell-Free DNA to unpack real-world data, practical use cases, and fresh perspectives on genetic medicine.
Presence & Recognition
Kardigan